Evolving Strategies in Manipulating VEGF/VEGFR Signaling for the Promotion of Angiogenesis in Ischemic Muscle

E-ISSN： 1873-4286|15|4|411-421

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.15, Iss.4, 2009-02, pp. : 411-421

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

VEGF/VEGFR₂ Signaling Regulates Germ Cell Proliferation in vitro and Promotes Mouse Testicular Regeneration in vivo

Cells Tissues Organs, Vol. 201, Iss. 1, 2015-0 ,pp. : 1-13

Karger

Access to resources Recommend Favorite

The Novel VEGF121-VEGF165 Fusion Attenuates Angiogenesis and Drug Resistance via Targeting VEGFR2-HIF-1-VEGF165/Lon Signaling Through PI3K-AKT-mTOR Pathway

Current Cancer Drug Targets, Vol. 16, Iss. 3, 2016-03 ,pp. : 275-286

Bentham Science Publishers

Access to resources Recommend Favorite

VEGF/VEGFR Pathway Inhibitors as Anti-Angiogenic Agents: Present and Future

Current Cancer Drug Targets, Vol. 11, Iss. 5, 2011-01 ,pp. : 624-653

Bentham Science Publishers

Access to resources Recommend Favorite

VEGF-VEGFR System as a Target for Suppressing Inflammation and other Diseases

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 15, Iss. 2, 2015-06 ,pp. : 135-144

Bentham Science Publishers

Access to resources Recommend Favorite

Moving Beyond VEGF for Anti-angiogenesis Strategies in Gynecologic Cancer

Current Pharmaceutical Design, Vol. 18, Iss. 19, 2012-06 ,pp. : 2713-2719

Bentham Science Publishers

Access to resources Recommend Favorite